Screening of large numbers of Streptococcus pneumoniae isolates for mutations associated with fluoroquinolone resistance using an oligonucleotide probe assay

被引:8
作者
Davies, TA [1 ]
Goldschmidt, R [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ 08869 USA
关键词
Streptococcus pneumoniae; fluoroquinolone resistant; oligonucleotide probe;
D O I
10.1111/j.1574-6968.2002.tb11478.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mutations at a relatively small number of sites in parC, parE and gyrA account for most of the fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates. A high throughput oligonucleotide probe assay was developed to screen for mutations in the quinolone-resistance determining region (QRDR) of parC (Ser79), gyrA (Ser81) and parE (Asp435) of Streptococcus pneumoniae. Eight oligonucleotide probes (17mers) were used in the presence of tetramethyl ammonium chloride so that the melting temperature was dependent on length and not on base composition. Using this assay it was possible to accurately detect QRDR mutations from several hundred S. pneumoniae clinical isolates that were grown on nylon membranes. (C) 2002 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 10 条
[1]   Fluoroquinolone resistance among recent clinical isolates of Streptococcus pneumoniae [J].
Barry, AL ;
Brown, SD ;
Fuchs, PC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (03) :428-429
[2]   Antipneumococcal activities of gemifloxacin compared to those of nine other agents [J].
Davies, TA ;
Kelly, LM ;
Pankuch, GA ;
Credito, KL ;
Jacobs, MR ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :304-310
[3]   Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000 [J].
Davies, TA ;
Evangelista, A ;
Pfleger, S ;
Bush, K ;
Sahm, DF ;
Goldschmidt, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :119-124
[4]   THE THERMAL-STABILITY OF OLIGONUCLEOTIDE DUPLEXES IS SEQUENCE INDEPENDENT IN TETRAALKYLAMMONIUM SALT-SOLUTIONS - APPLICATION TO IDENTIFYING RECOMBINANT DNA CLONES [J].
JACOBS, KA ;
RUDERSDORF, R ;
NEILL, SD ;
DOUGHERTY, JP ;
BROWN, EL ;
FRITSCH, EF .
NUCLEIC ACIDS RESEARCH, 1988, 16 (10) :4637-4650
[5]   Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters:: 1997 US surveillance study [J].
Jacobs, MR ;
Bajaksouzian, S ;
Zilles, A ;
Lin, GR ;
Pankuch, GA ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1901-1908
[6]   Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season [J].
Jones, ME ;
Sahm, DF ;
Martin, N ;
Scheuring, S ;
Heisig, P ;
Thornsberry, C ;
Köhrer, K ;
Schmitz, FJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :462-466
[7]   Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae [J].
Pan, XS ;
Ambler, J ;
Mehtar, S ;
Fisher, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2321-2326
[8]   Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States:: 2-year longitudinal analysis [J].
Sahm, DF ;
Karlowsky, JA ;
Kelly, LJ ;
Critchley, IA ;
Jones, ME ;
Thornsberry, C ;
Mauriz, Y ;
Kahn, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1037-1042
[9]  
Sambrook J., 2002, MOL CLONING LAB MANU
[10]   BASE COMPOSITION-INDEPENDENT HYBRIDIZATION IN TETRAMETHYLAMMONIUM CHLORIDE - A METHOD FOR OLIGONUCLEOTIDE SCREENING OF HIGHLY COMPLEX GENE LIBRARIES [J].
WOOD, WI ;
GITSCHIER, J ;
LASKY, LA ;
LAWN, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (06) :1585-1588